SCHEMBL17308554

SCHEMBL17308554

CCc1cc(N[C@H]2CC[C@@H](O)CC2)ncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 12/20 0.47
FLT3 P36888 11/20 0.47
TYRO3 Q06418 11/20 0.47
GAS6 Q14393 11/20 0.47
EGFR P00533 1/20 0.43
INSR P06213 1/20 0.43
LCK P06239 1/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
ALOX15 P16050 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
HRH4 Q9H3N8 1/20 0.41
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17345683 1.00 MERTK (0.47) MERTKFLT3TYRO3GAS6EGFR
SCHEMBL15833963 0.86 NAE1 (0.39) MERTKFLT3TYRO3GAS6MEN1
SCHEMBL19633535 0.86 HRH4 (0.51) MERTKFLT3TYRO3GAS6MEN1
SCHEMBL19633378 0.86 NAE1 (0.39) MERTKFLT3TYRO3GAS6MEN1
SCHEMBL15830289 0.86 MEN1 (0.53) MERTKFLT3TYRO3GAS6MEN1
SCHEMBL19957823 0.85 MEN1 (0.42) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL17308566 0.83 PRCP (0.44) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL15834731 0.83 PRCP (0.39) PDGFRBPDGFRAMEN1KMT2ACYP1A2
SCHEMBL7764364 0.82 CYP1A2 (0.40) MERTKFLT3TYRO3GAS6MEN1
SCHEMBL15834612 0.82 IRAK4 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150344434-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344434-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 MERTK 2311/4885FLT3 1034/4885TYRO3 3771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.